Maria A. VanVolkenburg

Author

Also Known As

M A VanVolkenburg, M.A. VanVolkenburg, M.A. Vanvolkenburg, MARIA A. VANVOLKENBURG, Maria A. VanVolkenburg, Maria A. Vanvolkenburg, Maria VanVolkenburg, VanVolkenburg, M.A.

Publications

430

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (Japan)

About

Maria A. VanVolkenburg is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	385
2	Biochemistry	9	9	345
3	Natural Sciences	8	8	276
4	Health Sciences	2	2	91
5	Cell Biology	1	1	18

Maria A. VanVolkenburg

Publications

425

Citations

H-Index

Page 1

	Year	Citations
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate Samit K. Bhattacharya, Kim Andrews, Ramsay E. Beveridge, ACS Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryG Protein-coupled ReceptorMedicine	2014	67
Cyclic AMP Phosphodiesterases of Human and Rat Islets of Langerhans: Contributions of Types III and IV to the Modulation of Insulin Secretion Jeremy C. Parker, Maria A. VanVolkenburg, Robert J. Ketchum, Biochemical and Biophysical Research Communications Pde InhibitorsInsulin SignalingMetabolic SyndromeTypes IiiInsulin Delivery	1995	59
Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. Jeremy C. Parker, Maria A. VanVolkenburg, Carolyn B. Levy, Diabetes Glucose-6-phosphate TranslocaseExperimental PharmacologyInsulin SignalingMetabolic SyndromeGlycogen Content	1998	57
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: A potent, selective, orally active dipeptidyl peptidase IV inhibitor Mark Ammirati, Kim Andrews, David Boyer, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2009	43
<i>cis</i>-2,5-Dicyanopyrrolidine Inhibitors of Dipeptidyl Peptidase IV: Synthesis and in Vitro, in Vivo, and X-ray Crystallographic Characterization Stephen W. Wright, Mark Ammirati, Kim Andrews, Journal of Medicinal Chemistry GlycobiologyChemical BiologyPharmaceutical ChemistryX-ray Crystallographic CharacterizationMedicinal Chemistry	2006	34
Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase III Janice C. Parker, Maria A. VanVolkenburg, Nancy A. Nardone, Biochemical and Biophysical Research Communications Selective InhibitionMetabolic SyndromeDiabetes ManagementBiochemistryMedicine	1997	32
Thielavins as Glucose-6-phosphatase (G6Pase) Inhibitors: Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities. Shinichi Sakemi, Hideo Hirai, Toshio Ichiba, The Journal of Antibiotics	2002	29
Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example Markus Boehm, David Hepworth, Paula M. Loria, ACS Medicinal Chemistry Letters Hit IdentificationGlycobiologyOrphan Gpcrs UsingCase ExampleChemistry	2013	27
Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors Jeffrey W. Corbett, Kenneth J. DiRico, Weibin Song, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDpp-iv InhibitorsBenzyl-substituted Cis-3-amino-4-Natural SciencesMedicine	2007	22
Development of a fluorescence-based<i>in vivo</i>phagocytosis assay to measure mononuclear phagocyte system function in the rat Karrie Tartaro, Maria A. VanVolkenburg, Dean Wilkie, Journal of Immunotoxicology Mps FunctionImmunocytochemical TechniqueImmunologyBlood CellPathology	2014	18

Page 1